Evolution of Fetal Growth in Symptomatic Sars-Cov-2 Pregnancies

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Jens Hachenberg - , Medizinische Hochschule Hannover (MHH) (Autor:in)
  • Julia Guenther - , Medizinische Hochschule Hannover (MHH) (Autor:in)
  • Lena Steinkasserer - , Medizinische Hochschule Hannover (MHH) (Autor:in)
  • Lars Brodowski - , Medizinische Hochschule Hannover (MHH) (Autor:in)
  • Ansgard Lena Dueppers - , Medizinische Hochschule Hannover (MHH) (Autor:in)
  • Maria Delius - , Ludwig-Maximilians-Universität München (LMU) (Autor:in)
  • Loredana Delle Chiaie - , City of Stuttgart (Autor:in)
  • Silvia Lobmaier - , Technische Universität München (Autor:in)
  • Marina Sourouni - , Westfälische Wilhelms-Universität Münster (Autor:in)
  • Manuela F. Richter - , Kkb (Autor:in)
  • Jula Manz - , Klinikum Darmstadt (Autor:in)
  • Olaf Parchmann - , Helios Klinik Sangerhausen (Autor:in)
  • Saskia Schmidt - , Sana Kliniken AG (Autor:in)
  • Jennifer Winkler - , Universitätsklinikum Carl Gustav Carus Dresden (Autor:in)
  • Pia Werring - , Christophorus Kliniken Coesfeld (Autor:in)
  • Katrina Kraft - , München Klinik Harlaching (Autor:in)
  • Mirjam Kunze - , Universitätsklinikum Freiburg (Autor:in)
  • Maike Manz - , Universität Heidelberg (Autor:in)
  • Christian Eichler - , St. Franziskus-Hospital Münster (Autor:in)
  • Viola Schaefer - , Universitätsklinikum Gießen und Marburg GmbH (Autor:in)
  • Martin Berghaeuser - , Florence Nightingale Krankenhaus Düsseldorf-Kaiserswerth (Autor:in)
  • Dietmar Schlembach - , Vivantes Klinikum Neukölln (Autor:in)
  • Sven Seeger - , Krankenhaus St. Elisabeth und St. Barbara (Autor:in)
  • Ute Schäfer-Graf - , St. Joseph Krankenhaus Berlin Tempelhof (Autor:in)
  • Ioannis Kyvernitakis - , Philipps-Universität Marburg (Autor:in)
  • Michael K. Bohlmann - , St. Elisabethen-Krankenhaus Lörrach gGmbH (Autor:in)
  • Babette Ramsauer - , Vivantes Klinikum Neukölln (Autor:in)
  • Christine Angela Morfeld - , Diakovere gGmbH (Autor:in)
  • Mario Ruediger - , Klinik und Poliklinik für Kinder- und Jugendmedizin, Zentrum für feto-neonatale Gesundheit (Autor:in)
  • Ulrich Pecks - , Universitätsklinikum Schleswig-Holstein Campus Kiel (Autor:in)
  • Constantin Von Kaisenberg - , Medizinische Hochschule Hannover (MHH) (Autor:in)

Abstract

Introduction SARS-CoV-2 is a viral disease with potentially devastating effects. Observational studies of pregnant women infected with SARS-CoV-2 report an increased risk for FGR. This study utilizes data from a prospective SARS-CoV-2 registry in pregnancy, investigating the progression of fetuses to fetal growth restriction (FGR) at birth following maternal SARS-CoV-2 and evaluating the hypothesis of whether the percentage of SGA at birth is increased after maternal SARS-CoV-2 taking into account the time interval between infection and birth. Materials & Methods CRONOS is a prospective German registry enrolling pregnant women with confirmed SARS-CoV-2 infection during their pregnancy. SARS-CoV-2 symptoms, pregnancy- and delivery-specific information were recorded. The data evaluated in this study range from March 2020 until August 2021. Women with SARS-CoV-2 were divided into three groups according to the time of infection/symptoms to delivery: Group I<2 weeks, Group II 2-4 weeks, and Group III>4 weeks. FGR was defined as estimated and/or birth weight<10% ile, appropriate for gestational age (AGA) was within 10 and 90%ile, and large for gestational age (LGA) was defined as fetal or neonatal weight>90%ile. Results Data for a total of 2,650 SARS-CoV-2-positive pregnant women were available. The analysis was restricted to symptomatic cases that delivered after 24+0 weeks of gestation. Excluding those cases with missing values for estimated fetal weight at time of infection and/or birth weight centile, 900 datasets remained for analyses. Group I consisted of 551 women, Group II of 112 women, and Group III of 237 women. The percentage of changes from AGA to FGR did not differ between groups. However, there was a significantly higher rate of large for gestational age (LGA) newborns at the time of birth compared to the time of SARS-CoV-2 infection in Group III (p=0.0024), respectively. Conclusion FGR rates did not differ between symptomatic COVID infections occurring within 2 weeks and>4 weeks before birth. On the contrary, it presented a significant increase in LGA pregnancies in Group III. However, in this study population, an increase in the percentage of LGA may be attributed to pandemic measures and a reduction in daily activity.

Titel in Übersetzung
Entwicklung des fetalen Wachstums bei symptomatischen SARS-CoV-2-Schwangerschaften

Details

OriginalspracheEnglisch
Seiten (von - bis)57-64
Seitenumfang8
FachzeitschriftZeitschrift fur Geburtshilfe und Neonatologie
Jahrgang228
Ausgabenummer1
PublikationsstatusVeröffentlicht - 18 Juli 2023
Peer-Review-StatusJa

Externe IDs

PubMed 38330960

Schlagworte

Schlagwörter

  • COVID-19, fetal growth restriction, large for gestational age, outcome, pregnancy, SARS-CoV-2